Artivion

Update in progress

AORT (NYSE)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Artivion, Inc. develops, manufactures, and distributes medical devices and implantable tissues worldwide. Its portfolio includes On-X heart valves, a range of stent grafts and vascular products, arterial and vascular grafts, surgical sealants, tissue patches, and preservation or decellularization services. Products are marketed mainly to hospitals via a direct sales force. Formerly CryoLife, renamed in 2022. Based in Kennesaw, Georgia.

Company score

Sentiment: 0.24; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.13; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.19; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.00; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.12; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive